Globus Medical, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $636.0M | $564.0M | $544.8M | $474.4M | $434.5M | $386.0M | $331.5M | $288.2M |
| Cost of Revenue | $150.5M | $134.7M | $132.3M | $110.8M | $100.3M | $75.2M | $68.8M | $53.8M |
| Gross Profit | $485.5M | $429.3M | $412.4M | $363.6M | $334.1M | $310.8M | $262.7M | $234.4M |
| Gross Margin | 76.3% | 76.1% | 75.7% | 76.6% | 76.9% | 80.5% | 79.2% | 81.3% |
| Operating Expenses | ||||||||
| Research & Development | $43.7M | $44.5M | $36.3M | $31.2M | $26.9M | $27.9M | $23.5M | $21.3M |
| SG&A Expense | $267.8M | $222.2M | $210.2M | $188.6M | $182.5M | $168.9M | $140.4M | $122.6M |
| Operating Income | $161.8M | $154.1M | $172.2M | $138.4M | $101.7M | $114.8M | $97.4M | $87.7M |
| Operating Margin | 25.4% | 27.3% | 31.6% | 29.2% | 23.4% | 29.7% | 29.4% | 30.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $169.9M | $157.3M | $172.8M | $138.6M | $102.0M | $114.7M | $96.9M | $87.7M |
| Income Tax Expense | $62.6M | $52.9M | $60.0M | $46.2M | $33.4M | $40.8M | $36.2M | $33.3M |
| Net Income | $107.3M | $104.3M | $112.8M | $92.5M | $68.6M | $73.8M | $60.8M | $54.5M |
| Net Margin | 16.9% | 18.5% | 20.7% | 19.5% | 15.8% | 19.1% | 18.3% | 18.9% |
| EPS (Basic) | $1.12 | $1.09 | $1.19 | $0.98 | $0.74 | $0.82 | $0.69 | $0.61 |
| EPS (Diluted) | $1.10 | $1.08 | $1.17 | $0.97 | $0.73 | $0.80 | $0.67 | $0.60 |
| Shares Outstanding (Basic) | 96.2M | 95.6M | 95.0M | 94.2M | 92.6M | 89.6M | 88.1M | 88.9M |
| Shares Outstanding (Diluted) | 97.9M | 96.4M | 96.1M | 95.5M | 94.2M | 92.2M | 90.4M | 91.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |